Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,850 | -9,070 | -4,525 | -10,243 | -11,059 |
| Depreciation Amortization | 513 | 342 | 171 | 680 | 509 |
| Accounts payable and accrued liabilities | 532 | 78 | 212 | 92 | 129 |
| Other Working Capital | 1,783 | 466 | 196 | -577 | 368 |
| Other Operating Activity | -424 | -35 | -240 | -3,799 | 383 |
| Operating Cash Flow | $-12,447 | $-8,219 | $-4,187 | $-13,847 | $-9,670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | N/A | N/A | -71 | -71 |
| Investing Cash Flow | $-6 | $N/A | $N/A | $-71 | $-71 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,945 | 13,945 | 966 | 15,613 | 11,818 |
| Financing Cash Flow | $13,945 | $13,945 | $966 | $15,613 | $11,818 |
| Beginning Cash Position | 17,392 | 17,392 | 17,392 | 15,696 | 15,696 |
| End Cash Position | 18,884 | 23,117 | 14,171 | 17,392 | 17,774 |
| Net Cash Flow | $1,492 | $5,726 | $-3,221 | $1,695 | $2,077 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,447 | -8,219 | -4,187 | -13,847 | -9,670 |
| Capital Expenditure | -6 | N/A | N/A | -71 | -71 |
| Free Cash Flow | -12,453 | -8,219 | -4,187 | -13,918 | -9,741 |